Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Physical Activity in the Hospital: Documentation and Influence on Venous Thromboembolism Prophylaxis.

Pavon JM, Sloane RJ, Pieper CF, Colón-Emeric CS, Gallagher D, Cohen HJ, Hall KS, Morey MC, McCarty M, Ortel TL, Hastings SN.

J Aging Phys Act. 2019 Nov 17:1-5. doi: 10.1123/japa.2018-0462. [Epub ahead of print]

PMID:
31743088
2.

Design and Implementation of a Comprehensive Surveillance System for Venous Thromboembolism in a Defined Region Using Electronic and Manual Approaches.

Ortel TL, Arnold K, Beckman M, Brown A, Reyes N, Saber I, Schulteis R, Singh BP, Sitlinger A, Thames EH.

Appl Clin Inform. 2019 May;10(3):552-562. doi: 10.1055/s-0039-1693711. Epub 2019 Jul 31.

PMID:
31365941
3.

Evaluation of a rapid and automated heparin-induced thrombocytopenia immunoassay.

Refaai MA, Conley G, Ortel TL, Francis JL.

Int J Lab Hematol. 2019 Aug;41(4):478-484. doi: 10.1111/ijlh.13029. Epub 2019 Apr 15.

4.

Three-factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis.

Hashmi NK, Ghadimi K, Srinivasan AJ, Li YJ, Raiff RD, Gaca JG, Root AG, Barac YD, Ortel TL, Levy JH, Welsby IJ.

Vox Sang. 2019 May;114(4):374-385. doi: 10.1111/vox.12774. Epub 2019 Apr 2.

PMID:
30937927
5.

Bad weed: synthetic cannabinoid-associated coagulopathy.

Arepally GM, Ortel TL.

Blood. 2019 Feb 28;133(9):902-905. doi: 10.1182/blood-2018-11-876839. Epub 2019 Jan 17. Review.

PMID:
30655273
6.

Introduction to a review series on new therapeutics for inherited and acquired bleeding conditions.

Ortel TL.

Blood. 2019 Jan 31;133(5):383-384. doi: 10.1182/blood-2018-12-877779. Epub 2018 Dec 17. No abstract available.

PMID:
30559265
7.

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.

Streiff MB, Holmstrom B, Angelini D, Ashrani A, Bockenstedt PL, Chesney C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Hendrie P, Lee AI, Lee JT, Mann J, McMahon B, Millenson MM, Morton C, Ortel TL, Ozair S, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Williams E, Zakarija A, Hammond L, Dwyer MA, Engh AM.

J Natl Compr Canc Netw. 2018 Nov;16(11):1289-1303. doi: 10.6004/jnccn.2018.0084.

PMID:
30442731
8.

Automated versus Manual Data Extraction of the Padua Prediction Score for Venous Thromboembolism Risk in Hospitalized Older Adults.

Pavon JM, Sloane RJ, Pieper CF, Colón-Emeric CS, Cohen HJ, Gallagher D, Morey MC, McCarty M, Ortel TL, Hastings SN.

Appl Clin Inform. 2018 Jul;9(3):743-751. doi: 10.1055/s-0038-1670678. Epub 2018 Sep 26.

9.

Extended anticoagulation for unprovoked venous thromboembolism.

Castellucci LA, de Wit K, Garcia D, Ortel TL, Le Gal G.

Res Pract Thromb Haemost. 2018 Jun 6;2(3):529-534. doi: 10.1002/rth2.12121. eCollection 2018 Jul. Review.

10.

Laboratory criteria for antiphospholipid syndrome: reply.

Devreese KMJ, Ortel TL, Pengo V, de Laat B.

J Thromb Haemost. 2018 Oct;16(10):2117-2119. doi: 10.1111/jth.14238. Epub 2018 Aug 16. No abstract available.

PMID:
30007111
11.

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH.

Devreese KMJ, Ortel TL, Pengo V, de Laat B; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.

J Thromb Haemost. 2018 Apr;16(4):809-813. doi: 10.1111/jth.13976. Epub 2018 Mar 13. No abstract available.

PMID:
29532986
12.

Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.

Onwuemene OA, Grambow SC, Patel CB, Mentz RJ, Milano CA, Rogers JG, Metjian AD, Arepally GM, Ortel TL.

J Clin Apher. 2018 Aug;33(4):469-479. doi: 10.1002/jca.21622. Epub 2018 Mar 10.

13.

Poor Adherence to Risk Stratification Guidelines Results in Overuse of Venous Thromboembolism Prophylaxis in Hospitalized Older Adults.

Pavon JM, Sloane RJ, Pieper CF, Colón-Emeric CS, Cohen HJ, Gallagher D, Morey MC, McCarty M, Ortel TL, Hastings SN.

J Hosp Med. 2018 Jun 1;13(6):403-404. doi: 10.12788/jhm.2916. Epub 2018 Feb 6. No abstract available.

14.

Bleeding and thrombotic complications of pediatric liver transplant.

Borst AJ, Sudan DL, Wang LA, Neuss MJ, Rothman JA, Ortel TL.

Pediatr Blood Cancer. 2018 May;65(5):e26955. doi: 10.1002/pbc.26955. Epub 2018 Jan 19.

15.

Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial.

Clark NP, Douketis JD, Hasselblad V, Schulman S, Kindzelski AL, Ortel TL; BRIDGE Investigators.

Am Heart J. 2018 Jan;195:108-114. doi: 10.1016/j.ahj.2017.09.015. Epub 2017 Sep 21.

16.

Variants in chondroitin sulfate metabolism genes in thrombotic storm.

Nuytemans K, Ortel TL, Gomez L, Hofmann N, Alves N, Dueker N, Beecham A, Whitehead P, Hahn Estabrooks S, Kitchens CS, Erkan D, Brandão LR, James AH, Kulkarni R, Manco-Johnson MJ, Pericak-Vance MA, Vance JM.

Thromb Res. 2018 Jan;161:43-51. doi: 10.1016/j.thromres.2017.11.016. Epub 2017 Nov 21.

17.

Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia.

Kuter DJ, Konkle BA, Hamza TH, Uhl L, Assmann SF, Kiss JE, Kaufman RM, Key NS, Sachais BS, Hess JR, Ness P, McCrae KR, Leissinger C, Strauss RG, McFarland JG, Neufeld E, Bussel JB, Ortel TL.

Am J Hematol. 2017 Aug;92(8):730-738. doi: 10.1002/ajh.24759. Epub 2017 Apr 26.

18.

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.

Rodger MA, Le Gal G, Anderson DR, Schmidt J, Pernod G, Kahn SR, Righini M, Mismetti P, Kearon C, Meyer G, Elias A, Ramsay T, Ortel TL, Huisman MV, Kovacs MJ; REVERSE II Study Investigators.

BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065.

19.

Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.

Khorana AA, Francis CW, Kuderer NM, Carrier M, Ortel TL, Wun T, Rubens D, Hobbs S, Iyer R, Peterson D, Baran A, Kaproth-Joslin K, Lyman GH.

Thromb Res. 2017 Mar;151:89-95. doi: 10.1016/j.thromres.2017.01.009. Epub 2017 Jan 26.

PMID:
28139259
20.

Associations between positive emotional well-being and stress-induced myocardial ischemia: Well-being scores predict exercise-induced ischemia.

Feigal JP, Boyle SH, Samad Z, Velazquez EJ, Wilson JL, Becker RC, Williams RB Jr, Kuhn CM, Ortel TL, Rogers JG, O'Connor CM, Jiang W.

J Psychosom Res. 2017 Feb;93:14-18. doi: 10.1016/j.jpsychores.2016.11.012. Epub 2016 Nov 29.

21.

2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.

Doherty JU, Gluckman TJ, Hucker WJ, Januzzi JL Jr, Ortel TL, Saxonhouse SJ, Spinler SA.

J Am Coll Cardiol. 2017 Feb 21;69(7):871-898. doi: 10.1016/j.jacc.2016.11.024. Epub 2017 Jan 9.

22.

Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients.

Sun JL, Boyle SH, Samad Z, Babyak MA, Wilson JL, Kuhn C, Becker RC, Ortel TL, Williams RB, Rogers JG, O'Connor CM, Velazquez EJ, Jiang W.

Eur J Prev Cardiol. 2017 Apr;24(6):591-599. doi: 10.1177/2047487316686435. Epub 2017 Jan 9.

23.

A rare cutaneous manifestation of hemorrhagic bullae to low-molecular-weight heparin and fondaparinux: report of two cases.

Komforti MK, Bressler ES, Selim MA, Bressler GS, Ortel TL.

J Cutan Pathol. 2017 Jan;44(1):104-106. doi: 10.1111/cup.12821. Epub 2016 Oct 21. No abstract available.

PMID:
27766660
24.

The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.

Welsby IJ, Krakow EF, Heit JA, Williams EC, Arepally GM, Bar-Yosef S, Kong DF, Martinelli S, Dhakal I, Liu WW, Krischer J, Ortel TL.

J Thromb Haemost. 2017 Jan;15(1):57-65. doi: 10.1111/jth.13533. Epub 2016 Nov 30.

25.

Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer.

Voora D, Rao AK, Jalagadugula GS, Myers R, Harris E, Ortel TL, Ginsburg GS.

EBioMedicine. 2016 Sep;11:157-164. doi: 10.1016/j.ebiom.2016.08.021. Epub 2016 Aug 14.

26.

Effect of intravenous lidocaine on the transcerebral inflammatory response during cardiac surgery: a randomized-controlled trial.

Klinger RY, Cooter M, Berger M, Podgoreanu MV, Stafford-Smith M, Ortel TL, Welsby IJ, Levy JH, Rinder HM, Newman MF, Mathew JP; Neurologic Outcomes Research Group (NORG) of The Duke Heart Center.

Can J Anaesth. 2016 Nov;63(11):1223-32. doi: 10.1007/s12630-016-0704-0. Epub 2016 Jul 28.

PMID:
27470233
27.

Bridging Anticoagulation in Patients with Atrial Fibrillation.

Douketis JD, Hasselblad V, Ortel TL.

N Engl J Med. 2016 Jan 7;374(1):93-4. doi: 10.1056/NEJMc1513255. No abstract available.

PMID:
26736004
28.

Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-risk Surgical and Medical Patients [Internet].

Pavon JM, Williams JW Jr, Adam SS, Razouki ZA, McDuffie JR, Lachiewicz PF, Kosinski AS, Beadles CA, Ortel TL, Nagi A.

Washington (DC): Department of Veterans Affairs (US); 2015 Jun.

29.

Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical Patients: A Systematic Review.

Pavon JM, Adam SS, Razouki ZA, McDuffie JR, Lachiewicz PF, Kosinski AS, Beadles CA, Ortel TL, Nagi A, Williams JW Jr.

J Arthroplasty. 2016 Feb;31(2):524-32. doi: 10.1016/j.arth.2015.09.043. Epub 2015 Oct 29. Review.

PMID:
26525487
30.

Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.

Streiff MB, Holmstrom B, Ashrani A, Bockenstedt PL, Chesney C, Eby C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Hendrie P, Kuderer N, Lee A, Lee JT, Lovrincevic M, Millenson MM, Neff AT, Ortel TL, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Yee GC, Zakarija A, McMillian N, Engh AM.

J Natl Compr Canc Netw. 2015 Sep;13(9):1079-95.

PMID:
26358792
31.

How I treat catastrophic thrombotic syndromes.

Ortel TL, Erkan D, Kitchens CS.

Blood. 2015 Sep 10;126(11):1285-93. doi: 10.1182/blood-2014-09-551978. Epub 2015 Jul 15. Review.

PMID:
26179082
32.

Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism.

Faiz AS, Khan I, Beckman MG, Bockenstedt P, Heit JA, Kulkarni R, Manco-Johnson M, Moll S, Ortel TL, Philipp CS.

Thromb Res. 2015 Sep;136(3):535-41. doi: 10.1016/j.thromres.2015.06.036. Epub 2015 Jul 5.

33.

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.

Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE Investigators.

N Engl J Med. 2015 Aug 27;373(9):823-33. doi: 10.1056/NEJMoa1501035. Epub 2015 Jun 22.

34.

Effects of red-cell storage duration on patients undergoing cardiac surgery.

Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, Granger S, Bennett-Guerrero E, Blajchman MA, Scavo V, Carson JL, Levy JH, Whitman G, D'Andrea P, Pulkrabek S, Ortel TL, Bornikova L, Raife T, Puca KE, Kaufman RM, Nuttall GA, Young PP, Youssef S, Engelman R, Greilich PE, Miles R, Josephson CD, Bracey A, Cooke R, McCullough J, Hunsaker R, Uhl L, McFarland JG, Park Y, Cushing MM, Klodell CT, Karanam R, Roberts PR, Dyke C, Hod EA, Stowell CP.

N Engl J Med. 2015 Apr 9;372(15):1419-29. doi: 10.1056/NEJMoa1414219.

35.

Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.

Schulman S, Zondag M, Linkins L, Pasca S, Cheung YW, de Sancho M, Gallus A, Lecumberri R, Molnar S, Ageno W, Le Gal G, Falanga A, Hulegårdh E, Ranta S, Kamphuisen P, Debourdeau P, Rigamonti V, Ortel TL, Lee A.

J Thromb Haemost. 2015 Jun;13(6):1010-8. doi: 10.1111/jth.12955. Epub 2015 May 9.

36.

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.

Francis CW, Kessler CM, Goldhaber SZ, Kovacs MJ, Monreal M, Huisman MV, Bergqvist D, Turpie AG, Ortel TL, Spyropoulos AC, Pabinger I, Kakkar AK.

J Thromb Haemost. 2015 Jun;13(6):1028-35. doi: 10.1111/jth.12923. Epub 2015 May 10.

37.

Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study.

Jiang W, Boyle SH, Ortel TL, Samad Z, Velazquez EJ, Harrison RW, Wilson J, Kuhn C, Williams RB, O'Connor CM, Becker RC.

Am Heart J. 2015 Apr;169(4):496-507.e1. doi: 10.1016/j.ahj.2014.12.002. Epub 2014 Dec 17.

38.

Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism.

Lewis DA, Suchindran S, Beckman MG, Hooper WC, Grant AM, Heit JA, Manco-Johnson M, Moll S, Philipp CS, Kenney K, De Staercke C, Pyle ME, Chi JT, Ortel TL.

Thromb Res. 2015 Apr;135(4):659-65. doi: 10.1016/j.thromres.2015.02.003. Epub 2015 Feb 7.

39.

Is it time for individualized thromboprophylaxis regimens in the ICU?

Welsby I, Ortel TL.

Crit Care Med. 2015 Feb;43(2):500-1. doi: 10.1097/CCM.0000000000000784. No abstract available.

PMID:
25599484
40.

Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?

Arepally GM, Ortel TL.

Annu Rev Med. 2015;66:241-53. doi: 10.1146/annurev-med-051113-024633. Review.

PMID:
25587651
41.

Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome.

Rabinovich A, Cohen JM, Cushman M, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, Tagalakis V, Lazo-Langner A, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Ginsberg JS, Kahn SR.

J Thromb Haemost. 2015 Mar;13(3):398-408. doi: 10.1111/jth.12814. Epub 2015 Feb 10.

42.

Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Yusuf HR, Hooper WC, Grosse SD, Parker CS, Boulet SL, Ortel TL.

Thromb Res. 2015 Jan;135(1):50-7. doi: 10.1016/j.thromres.2014.10.012. Epub 2014 Oct 22.

43.

Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study.

Samad Z, Boyle S, Ersboll M, Vora AN, Zhang Y, Becker RC, Williams R, Kuhn C, Ortel TL, Rogers JG, O'Connor CM, Velazquez EJ, Jiang W; REMIT Investigators.

J Am Coll Cardiol. 2014 Oct 21;64(16):1669-78. doi: 10.1016/j.jacc.2014.04.087. Erratum in: J Am Coll Cardiol. 2014 Dec 9;64(22):2438.

44.

Challenges and priorities for research: a report from the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH) Working Group on thrombosis in pediatric cardiology and congenital heart disease.

McCrindle BW, Li JS, Manlhiot C, Tweddell JS, Giglia TM, Massicotte MP, Monagle P, Krishnamurthy R, Mahaffey KW, Michelson AD, Verdun N, Almond CS, Newburger JW, Brandão LR, Esmon CT, Manco-Johnson MJ, Ichord R, Ortel TL, Chan AK, Portman R, Rose M, Strony J, Kaltman JR.

Circulation. 2014 Sep 30;130(14):1192-203. doi: 10.1161/CIRCULATIONAHA.113.008428. No abstract available.

PMID:
25266860
45.

Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial.

Kahn SR, Shapiro S, Ducruet T, Wells PS, Rodger MA, Kovacs MJ, Anderson D, Tagalakis V, Morrison DR, Solymoss S, Miron MJ, Yeo E, Smith R, Schulman S, Kassis J, Kearon C, Chagnon I, Wong T, Demers C, Hanmiah R, Kaatz S, Selby R, Rathbun S, Desmarais S, Opatrny L, Ortel TL, Galanaud JP, Ginsberg JS.

Thromb Haemost. 2014 Dec;112(6):1137-41. doi: 10.1160/TH14-05-0430. Epub 2014 Aug 28.

PMID:
25183442
46.

Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability.

Ellero-Simatos S, Lewis JP, Georgiades A, Yerges-Armstrong LM, Beitelshees AL, Horenstein RB, Dane A, Harms AC, Ramaker R, Vreeken RJ, Perry CG, Zhu H, Sànchez CL, Kuhn C, Ortel TL, Shuldiner AR, Hankemeier T, Kaddurah-Daouk R.

CPT Pharmacometrics Syst Pharmacol. 2014 Jul 16;3:e125. doi: 10.1038/psp.2014.22.

47.

The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study.

Vavalle JP, Rusconi CP, Zelenkofske S, Wargin WA, Ortel TL, Alexander JH, Povsic TJ, Becker RC.

J Thromb Thrombolysis. 2014 Oct;38(3):275-84. doi: 10.1007/s11239-014-1081-6.

PMID:
24880800
48.

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends.

Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, de Groot P, Lakos G, Lambert M, Meroni P, Ortel TL, Petri M, Rahman A, Roubey R, Sciascia S, Snyder M, Tebo AE, Tincani A, Willis R.

Autoimmun Rev. 2014 Sep;13(9):917-30. doi: 10.1016/j.autrev.2014.05.001. Epub 2014 May 10. Review.

PMID:
24824074
49.

Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH.

Devreese KM, Pierangeli SS, de Laat B, Tripodi A, Atsumi T, Ortel TL; Subcommittee on Lupus Anticoagulant/Phospholipid/Dependent Antibodies.

J Thromb Haemost. 2014 May;12(5):792-5. doi: 10.1111/jth.12537. No abstract available.

50.

Thromboprophylaxis with fondaparinux in high-risk postoperative patients with renal insufficiency.

Hester W, Fry C, Gonzalez D, Cohen-Wolkowiez M, Inman BA, Ortel TL.

Thromb Res. 2014 Apr;133(4):629-33. doi: 10.1016/j.thromres.2013.11.019. Epub 2013 Nov 23.

Supplemental Content

Loading ...
Support Center